MARKET

SNSE

SNSE

Sensei Biotherapeutics, Inc.
NASDAQ
27.68
+0.80
+2.98%
After Hours: 27.68 0 0.00% 17:12 03/27 EDT
OPEN
26.95
PREV CLOSE
26.88
HIGH
28.17
LOW
25.42
VOLUME
114.94K
TURNOVER
--
52 WEEK HIGH
36.76
52 WEEK LOW
5.00
MARKET CAP
34.91M
P/E (TTM)
-1.4446
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at SNSE last week (0316-0320)?
Weekly Report · 6d ago
Sensei Biotherapeutics grants employee stock option for 166,435 shares at USD 29.37
Reuters · 03/17 10:00
SENSEI BIOTHERAPEUTICS ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)
Reuters · 03/17 10:00
Weekly Report: what happened at SNSE last week (0309-0313)?
Weekly Report · 03/16 09:07
Weekly Report: what happened at SNSE last week (0302-0306)?
Weekly Report · 03/09 09:07
Weekly Report: what happened at SNSE last week (0223-0227)?
Weekly Report · 03/02 09:07
Sensei Biotherapeutics Grants 2.32M Inducement Stock Options to 17 New Employees
Reuters · 02/25 11:00
SENSEI BIOTHERAPEUTICS ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)
Reuters · 02/25 11:00
More
About SNSE
Sensei Biotherapeutics, Inc. is a clinical-stage biotechnology company focused on the discovery and development of next-generation therapeutics for cancer patients. The Company's lead program is PIKTOR, an investigational multi-node inhibitor of the PI3K/AKT/mTOR pathway in development for endometrial and breast cancer. The Company is also completing a Phase I/II trial of solnerstotug, its V-domain Ig suppressor of T cell activation (VISTA) inhibitor, in patients with advanced solid tumors. Its TMAb platform is designed to enable highly selective targeting through conditional antibody activation of immune cells in the tumor microenvironment without on-target, off-tumor activity. Its programs include Solnerstotug (SNS-101), SNS-102, SNS-103, and SNS-201. Solnerstotug is a conditionally active, human monoclonal IgG1 antibody designed to block the VISTA checkpoint, which acts as a suppressor of T cells by binding the receptor PSGL-1.

Webull offers Sensei Biotherapeutics Inc stock information, including NASDAQ: SNSE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SNSE stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SNSE stock methods without spending real money on the virtual paper trading platform.